Dataset Information

Protective Role of Peroxisome Proliferator-Activated Receptor-? in the Development of Intracranial Aneurysm Rupture.

ABSTRACT: Inflammation is emerging as a key component of the pathophysiology of intracranial aneurysms. Peroxisome proliferator-activated receptor-? (PPAR?) is a nuclear hormone receptor of which activation modulates various aspects of inflammation.Using a mouse model of intracranial aneurysm, we examined the potential roles of PPAR? in the development of rupture of intracranial aneurysm.A PPAR? agonist, pioglitazone, significantly reduced the incidence of ruptured aneurysms and the rupture rate without affecting the total incidence aneurysm (unruptured aneurysms and ruptured aneurysms). PPAR? antagonist (GW9662) abolished the protective effect of pioglitazone. The protective effect of pioglitazone was absent in mice lacking macrophage PPAR?. Pioglitazone treatment reduced the mRNA levels of inflammatory cytokines (monocyte chemoattractant factor-1, interleukin-1, and interleukin-6) that are primarily produced by macrophages in the cerebral arteries. Pioglitazone treatment reduced the infiltration of M1 macrophage into the cerebral arteries and the macrophage M1/M2 ratio. Depletion of macrophages significantly reduced the rupture rate.Our data showed that the activation of macrophage PPAR? protects against the development of aneurysmal rupture. PPAR? in inflammatory cells may be a potential therapeutic target for the prevention of aneurysmal rupture.

SUBMITTER: Shimada K

PROVIDER: S-EPMC4447500 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture.

Shimada Kenji K Furukawa Hajime H Wada Kosuke K Korai Masaaki M Wei Yuan Y Tada Yoshiteru Y Kuwabara Atsushi A Shikata Fumiaki F Kitazato Keiko T KT Nagahiro Shinji S Lawton Michael T MT Hashimoto Tomoki T

Stroke 20150430 6

<h4>Background and purpose</h4>Inflammation is emerging as a key component of the pathophysiology of intracranial aneurysms. Peroxisome proliferator-activated receptor-γ (PPARγ) is a nuclear hormone receptor of which activation modulates various aspects of inflammation.<h4>Methods</h4>Using a mouse model of intracranial aneurysm, we examined the potential roles of PPARγ in the development of rupture of intracranial aneurysm.<h4>Results</h4>A PPARγ agonist, pioglitazone, significantly reduced the ...[more]

PMID: 25931465

Similar Datasets

Project description:Vascular inflammation plays a critical role in the pathogenesis of cerebral aneurysms. Peroxisome proliferator-activated receptor ? (PPAR?) protects against vascular inflammation and atherosclerosis, whereas dominant-negative mutations in PPAR? promote atherosclerosis and vascular dysfunction. We tested the role of PPAR? in aneurysm formation and rupture. Aneurysms were induced with a combination of systemic infusion of angiotensin-II and local injection of elastase in (1) mice that received the PPAR? antagonist GW9662 or the PPAR? agonist pioglitazone, (2) mice carrying dominant-negative PPAR? mutations in endothelial or smooth muscle cells, and (3) mice that received the Cullin inhibitor MLN4924. Incidence of aneurysm formation, rupture, and mortality was quantified. Cerebral arteries were analyzed for expression of Cullin3, Kelch-like ECH-associated protein 1, nuclear factor (erythroid-derived 2)-like 2, NAD(P)H dehydrogenase (quinone)1 (NQO1), and inflammatory marker mRNAs. Neither pioglitazone nor GW9662 altered the incidence of aneurysm formation. GW9662 significantly increased the incidence of aneurysm rupture, whereas pioglitazone tended to decrease the incidence of rupture. Dominant-negative endothelial-specific PPAR? did not alter the incidence of aneurysm formation or rupture. In contrast, dominant-negative smooth muscle-specific PPAR? resulted in an increase in aneurysm formation (P<0.05) and rupture (P=0.05). Dominant-negative smooth muscle-specific PPAR?, but not dominant-negative endothelial-specific PPAR?, resulted in significant decreases in expression of genes encoding Cullin3, Kelch-like ECH-associated protein 1, and nuclear factor (erythroid-derived 2)-like 2, along with significant increases in tumor necrosis factor-?, monocyte chemoattractant protein-1, chemokine (C-X-C motif) ligand 1, CD68, matrix metalloproteinase-3, -9, and -13. MLN4924 did not alter incidence of aneurysm formation, but increased the incidence of rupture (P<0.05). In summary, endogenous PPAR?, specifically smooth muscle PPAR?, plays an important role in protecting from formation and rupture of experimental cerebral aneurysms in mice.

Dataset Information

Protective Role of Peroxisome Proliferator-Activated Receptor-? in the Development of Intracranial Aneurysm Rupture.

Publications

Protective Role of Peroxisome Proliferator-Activated Receptor-γ in the Development of Intracranial Aneurysm Rupture.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure